Zusammenfassung
Zur medikamentösen Tumortherapie zählen die Chemotherapie, die Hormontherapie, die Immuntherapie einschließlich der Gentherapie sowie die differenzierungsinduzierende Therapie.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304:10–15
Day RS (1986) Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy. Cancer Res 46:3878–3885
DeVita VT, Schein PS (1973) The use of drugs in combination for the treatment of cancer. Rationale and results. N Engl J Med 288:998–1006
DeVita VT (1983) The relationship between tumor mass and resistance to treatment of cancer. Cancer 51: 1209–1220
DeVita VT, Hubbard JM, Longo DL (1987) The chemotherapy of the lymphomas: looking back, moving forward — the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 47:5819–5824
Fisher RI, Gaynor ER, Dahlberg S et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328:1002–1006
Goldie JH, Coldman AJ (1983) Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 67:923–931
Hartmann F, Renner C, Jung W, Pfreundschuh M et al (2001) Anti-CD16/CD30 bispecific antibody treatment for Hodgkins disease: Role of infusion schedule and costimulation with cytokines. Clin Cancer Res 7:1873–1881
Hasenclever D, Brosteanu O, Gerike T, Loeffler M (2001) Modelling of chemotherapy: The effective dose approach. Ann Hematol 80:B98–B94
Hryniuk WA, Figueredo A, Goodyear M (1987) Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin Oncol 14 (Suppl 4):3–11
Hryniuk W, Frei E, Wright FA (1998) A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity. J Clin Oncol 16:3137–3147
Norton L (1982) Mathematical interpretation of tumor growth kinetics. In: Greenspan EM (ed) Clinical interpretation and practice of cancer chemotherapy. Raven Press, New York, pp 53–70
Nowell PC (1986) The clonal evolution of tumor cell populations. Science 194:23–28
Pfreundschuh MG, Rueffer U, Lathan B et al (1994) Dexa-BEAM in patients with Hodgkin’s disease refractory to multidrug chemotherapy regimens: A trial of the German Hodgkin’s Disease Study Group. J Clin Oncol 12:580–586
Pfreundschuh M, Haseneclever D, Loeffler M et al (2001) Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF. Ann Oncol 12:471–477
Pfreundschuh M, Truemper L, Kloess M et al (2002) 2-weekly vs. 3-weekly CHOP with and without etoposide for patients >60 years of age with aggressive non-Hodgkin\(Cs lymphomas: results of the completed NHL-B-2-trial of the DSHNHL. Blood 100:774a
Skipper HE (1986) Laboratory models: the historical perspective. Cancer Treat Rep 70:3–7
Skipper HE, Schabel FM Jr, Wilcox WS (1964) Experimental evaluation of potential anticancer agents: XII. On the criteria and kinetics associated with „curability“ of experimental leukemia. Cancer Chemother Rep 35:1–111
Watson JV (1976) The cell proliferation kinetics of the EMT6/M/AC mouse tumours at four volumes during unperturbed growth in vivo. Cell Tissue Kent 9:147–156
Wilson WH, Bryant G, Bates S et al (1993) EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin’s lymphoma. J Clin Oncol 11:1573–1582
WHO Handbook for Reporting Results of Cancer Treatment (1979) World Health Organization, Geneva
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Pfreundschuh, M. (2006). Prinzipien der medikamentösen Tumortherapie. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31303-6_40
Download citation
DOI: https://doi.org/10.1007/3-540-31303-6_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20657-6
Online ISBN: 978-3-540-31303-8
eBook Packages: Medicine (German Language)